Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson’s Disease, recent trial suggests

A safe and feasible treatment option for reducing the motor signs of Parkinson’s disease.

Viatris, Lexicon ink licensing deal; Capricor’s $75M offering

Plus, news about Kezar Life Sciences and Concentra Biosciences: Viatris, Lexicon Pharmaceuticals sign licensing deal for cardio drug: Per the agreement … Sign up to

October 18, 2024

How maternal diet composition influences offspring appetite and metabolic health

Researchers evaluated the impact of maternal dietary protein and carbohydrate balance on offspring’s appetite and metabolic health.

February 15, 2024

Who are the leading innovators in nucleotide analogues for the pharmaceutical industry?

However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve

November 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.